A detailed history of Royal London Asset Management LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Royal London Asset Management LTD holds 15,434 shares of CRL stock, worth $3.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,434
Previous 15,467 0.21%
Holding current value
$3.02 Million
Previous $3.2 Million 4.85%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$187.96 - $245.29 $6,202 - $8,094
-33 Reduced 0.21%
15,434 $3.04 Million
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $89,548 - $120,309
-440 Reduced 2.77%
15,467 $4.19 Million
Q4 2023

Feb 13, 2024

SELL
$164.52 - $238.84 $50,178 - $72,846
-305 Reduced 1.88%
15,907 $3.76 Million
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $65,434 - $88,632
-341 Reduced 2.06%
16,212 $3.27 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $210,353 - $288,872
-1,153 Reduced 6.51%
16,553 $3.26 Million
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $125,744 - $186,278
616 Added 3.6%
17,706 $3.79 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $1.22 Million - $1.73 Million
4,784 Added 38.88%
17,090 $4.85 Million
Q4 2021

Oct 18, 2022

BUY
$351.38 - $448.68 $3.15 Million - $4.02 Million
8,958 Added 267.56%
12,306 $4.64 Million
Q4 2021

Jan 18, 2022

BUY
$351.38 - $448.68 $3.15 Million - $4.02 Million
8,958 Added 267.56%
12,306 $4.64 Million
Q3 2021

Oct 18, 2022

SELL
$372.64 - $458.3 $5.35 Million - $6.58 Million
-14,358 Reduced 81.09%
3,348 $1.38 Million
Q3 2021

Nov 02, 2021

BUY
$372.64 - $458.3 $1.25 Million - $1.53 Million
3,348 New
3,348 $1.38 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.